Stockscreener 앱 받기
24.63
3.27%
0.78
시간 외 거래:
24.63
전일 마감가:
$23.85
열려 있는:
$25.04
하루 거래량:
2.82M
Relative Volume:
1.51
시가총액:
$1.68B
수익:
$1.01B
순이익/손실:
$-204.71M
주가수익비율:
-8.0252
EPS:
-3.0691
순현금흐름:
$-29.67M
1주 성능:
+17.99%
1개월 성능:
+32.99%
6개월 성능:
+95.94%
1년 성능:
+19.45%
1일 변동 폭
$24.18
$25.43
1주일 범위
$20.91
$25.43
52주 변동 폭
$9.98
$29.65
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
명칭
Tandem Diabetes Care Inc
전화
858-366-6900
주소
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
24.63 | 1.63B | 1.01B | -204.71M | -29.67M | -3.0691 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-17 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2026-02-23 | 업그레이드 | Lake Street | Hold → Buy |
| 2026-02-20 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2026-01-27 | 재개 | TD Cowen | Buy |
| 2025-12-16 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-10-21 | 재개 | Stifel | Hold |
| 2025-09-08 | 개시 | Oppenheimer | Outperform |
| 2025-08-12 | 업그레이드 | Citigroup | Sell → Neutral |
| 2025-08-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2025-06-16 | 개시 | Truist | Hold |
| 2025-04-10 | 개시 | Mizuho | Neutral |
| 2025-03-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-03-03 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | 개시 | Bernstein | Outperform |
| 2024-10-04 | 개시 | Goldman | Neutral |
| 2024-10-02 | 개시 | RBC Capital Mkts | Outperform |
| 2024-08-22 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-08-08 | 개시 | Canaccord Genuity | Buy |
| 2024-05-30 | 개시 | Redburn Atlantic | Buy |
| 2024-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-04-29 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | 업그레이드 | Stifel | Hold → Buy |
| 2023-08-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-05-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-04-24 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-26 | 개시 | Wolfe Research | Peer Perform |
| 2022-11-15 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-08-09 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Underweight |
| 2020-12-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | 개시 | Wells Fargo | Overweight |
| 2020-07-31 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-07-06 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-06-18 | 재확인 | Raymond James | Outperform |
| 2020-04-24 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-06 | 개시 | Raymond James | Outperform |
| 2020-02-04 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | 개시 | Guggenheim | Buy |
| 2019-10-04 | 업그레이드 | UBS | Neutral → Buy |
| 2019-05-17 | 재확인 | BofA/Merrill | Neutral |
| 2019-05-13 | 개시 | SVB Leerink | Outperform |
| 2019-03-08 | 개시 | BMO Capital Markets | Outperform |
| 2019-03-05 | 재확인 | BofA/Merrill | Neutral |
| 2019-02-27 | 재확인 | Lake Street | Buy |
| 2018-11-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | 재확인 | Dougherty & Company | Buy |
| 2018-09-26 | 재확인 | Piper Jaffray | Overweight |
모두보기
Tandem Diabetes Care Inc 주식(TNDM)의 최신 뉴스
Nvidia To $323? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
This Union Pacific Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday - Benzinga
Tandem Diabetes Care analysts boost their forecasts after upbeat Q4 results - MSN
Tandem Diabetes (TNDM) Receives Upgrade Amid Revenue Growth Pros - GuruFocus
Tandem Diabetes Care, Inc. (TNDM) reports Q4 loss, tops revenue estimates - MSN
Tandem Diabetes (TNDM) EVP exercises 7,414 RSUs and sells 187 shares - Stock Titan
Here’s why the Brown Capital Management Small Company Fund sold Tandem Diabetes Care (TNDM) - MSN
Lake Street upgrades Tandem Diabetes Care (TNDM) - MSN
Strength Seen in Tandem Diabetes Care (TNDM): Can Its 9.1% Jump Turn into More Strength? - Yahoo Finance
Reasons to hold Tandem Diabetes stock in your portfolio for now - MSN
Piper Sandler upgrades Tandem Diabetes Care (TNDM) - MSN
Tandem Diabetes (TNDM) Stock Upgraded by Piper Sandler Amid Stra - GuruFocus
Piper Sandler Upgrades Tandem Diabetes Care (TNDM) to Overweight - GuruFocus
Tandem Diabetes Care (TNDM) insider files resale notice; 2 shares sold at $45.62 - Stock Titan
Tandem Diabetes Care Stock Upgrade & Market Outlook 2026News and Statistics - IndexBox
Why Are Tandem Diabetes (TNDM) Shares Soaring Today - Yahoo Finance UK
Tandem Diabetes Bullish Call Signals Long-Term Growth ConfidenceTandem Diabetes Care (NASDAQ:TNDM) - Benzinga
TNDM Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Tandem stock rises as Piper Sandler upgrades (TNDM:NASDAQ) - Seeking Alpha
Global Diabetes Care Devices Market to Accelerate Substantially at a CAGR of ~7% by 2034 | DelveInsight - Bolsamania
Semtech To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
This Lemonade Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
Piper Sandler Upgrades Tandem Diabetes Care (TNDM) to Overweight | TNDM Stock News - GuruFocus
Tandem Diabetes Care Hits Day High with Strong 9.13% Intraday Surge - Markets Mojo
Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates - MSN
Aug Opening: Should value investors consider Tandem Diabetes Care IncDollar Strength & Risk Managed Investment Entry Signals - baoquankhu1.vn
Assessing Tandem Diabetes Care (TNDM) Valuation After Mixed Long Term Returns And Recent Share Price Strength - Sahm
Tandem Diabetes Android Launch Expands Access And Shapes TNDM Valuation Story - Yahoo Finance
Tandem Diabetes upgraded at Citi on risk-reward setup - MSN
Reasons to Hold Tandem Diabetes Stock in Your Portfolio for Now - Yahoo Finance
The Bull Case For Tandem Diabetes Care (TNDM) Could Change Following Android Launch Of Tandem Mobi App - Sahm
Citi Reaffirms Their Hold Rating on Tandem Diabetes Care (TNDM) - The Globe and Mail
Liquidity Mapping Around (TNDM) Price Events - Stock Traders Daily
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q4 2025 earnings call transcript - MSN
[Latest] Global Intravenous Infusion Pump Market Size/Share Worth USD 14.02 Billion by 2035 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
How Tandem Diabetes Care Inc. stock reacts to job market data2026 Opening Moves & Technical Analysis for Trade Confirmation - Naître et grandir
Why analysts maintain buy rating on Tandem Diabetes Care Inc. (TD5A) stockPortfolio Performance Summary & Weekly Breakout Watchlists - Naître et grandir
Is Tandem Diabetes Care Inc. stock a safe haven assetMarket Activity Summary & Free High Accuracy Swing Entry Alerts - Naître et grandir
Breakout Move: Is Tandem Diabetes Care Inc stock influenced by commodity pricesMarket Growth Report & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Aug Retail: Is Tandem Diabetes Care Inc. stock a safe haven assetEarnings Risk Summary & Low Drawdown Trading Techniques - Naître et grandir
PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know - Yahoo Finance
Medtronic’s MiniMed raises $560M in IPO priced below range - Modern Healthcare
Tandem Diabetes Care, Inc. $TNDM Position Trimmed by Vanguard Group Inc. - MarketBeat
Lake Street Downgrades Tandem Diabetes Care (TNDM) - MSN
Tandem Diabetes adds Android support for Mobi insulin pump By Investing.com - Investing.com Australia
Tandem Diabetes adds Android support for Mobi insulin pump - Investing.com Nigeria
Tandem Diabetes expands Mobi Insulin Pump to Android users - Medical Economics
Royce & Associates Invests in Tandem Diabetes Care - National Today
Royce & Associates LP Makes New Investment in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Tandem Mobi Android Launch Expands Access And Supports Recurring Revenue Story - Yahoo Finance
Tandem Diabetes Care Expands Tandem Mobi App Compatibility to Android Smartphones - geneonline.com
Tandem Diabetes Care Inc (TNDM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):